Parkinson's & Movement disorders
Appendix removal is linked to lower risk of Parkinson's
Scientists have found a new clue that Parkinson's disease may get its start not in the brain but in the gut—maybe in the appendix.
Oct 31, 2018
4
1166
Sorted by popular
Neuroscience
Copper leads to protein aggregation in Parkinson's disease
Copper exposure in the environment and the protein alpha-synuclein in the human brain could play an important role in the pathogenesis of Parkinson's disease. A team from Empa and the University of Limerick was able to show ...
Jul 7, 2022
0
99
Parkinson's & Movement disorders
Closer look at proteins involved in Parkinson's disease reveals segment involved in amyloid formation
(Medical Xpress)—A team of scientists from several research centers in the U.S. has taken a closer look at α-synuclein, a protein that is abundant in the human brain, and which is also involved in the development of Parkinson's ...
Parkinson's & Movement disorders
Study identifies key factor in neural death that causes Parkinson's disease
In studying the molecular biology of brain development, a team of researchers led by Ludwig Stockholm director Thomas Perlmann has discovered how disruption of a developmental mechanism alters the very nerve cells that are ...
Apr 28, 2015
0
819
Parkinson's & Movement disorders
Common diabetes drugs may prevent Parkinson's
Elevated risk of Parkinson's disease among people with type 2 diabetes appears to be reduced by some medications used to treat their diabetes, finds a new study led by UCL researchers.
Oct 27, 2020
0
55
Medical research
Vitamin B12 identified as the inhibitor of a key enzyme in hereditary Parkinson's disease
Iban Ubarretxena, an Ikerbasque researcher and director of the Biofisika Institute (CSIC-UPV/EHU), participated in a study that identified new inhibitors that could be used to develop drugs to combat Parkinson's. The research ...
Apr 3, 2019
0
563
Parkinson's & Movement disorders
Rice opens new window on Parkinson's disease
(Medical Xpress)—Rice University scientists have discovered a new way to look inside living cells and see the insoluble fibrillar deposits associated with Parkinson's disease.
Dec 17, 2012
0
0
Medications
How gut bacteria affect the treatment of Parkinson's disease
Patients with Parkinson's disease are treated with levodopa, which is converted into dopamine, a neurotransmitter in the brain. In a study published on 18 January in the journal Nature Communications, scientists from the ...
Jan 21, 2019
0
431
Medications
Does medical marijuana have a role in Parkinson's disease care?
At a conference hosted two years ago by the Parkinson's Foundation, many neurologists had a pressing issue on their minds: pot.
Jun 9, 2020
0
5
Parkinson's & Movement disorders
Parkinson's disease mutation misdirects iron in the brain
A common gene mutation for Parkinson's disease drives mislocalization of iron in activated microglia, according to a new study publishing December 16th in the open-access journal PLOS Biology, by Mark Cookson of the National ...
Dec 16, 2021
0
172
